Programme

 Scientific Programme DOWNLOAD

Thursday, January 30, 2020

Opening Talk

Time Presentation Title Speaker
08:30 – 09:00 Opening and Objectives Jolanta Kunikowska,
Ken Herrmann

 

Thursday, January 30, 2020

Imaging of NET

Chairpersons: tba

Time Presentation Title Speaker
09:00-09:25 Clinical and Biochemical Signs of NET Marianne Pavel
09:30-09:55 Contribution of Radiology for NET Imaging Anders Sundin
10:00-10:25 Contribution of Nuclear Medicine for NET Imaging Valentina Ambrosini
11:00-11:05 Controversy: Is there still a Role of Somatostatine Receptor Scintigraphy in NET? Kjell Öberg
11:05-11:25 In Favour Rodney John Hicks
11:25-11:45 Against Val Lewington
11:45-12:00 Discussion all
12:00-13:00 Consensus on Imaging of NET David Taïeb

 

Thursday, January 30, 2020

Imaging and Therapy of Pheochromocytoma and Paraganglioma

Chairpersons: tba

Time Presentation Title Speaker
14:00 – 14:25 Clinical, Biochemical and Genetic Behavior of Pheochromocytoma and Paraganglioma Aldo Scarpa
14:30 – 14:55 Contribution of Nuclear Medicine for Pheochromocytoma and Paraganglioma David Taïeb
15:00 – 15:25 Place of Radionuclide Therapy in Pheochromocytoma and Paraganglioma Irene Virgolini
16:00 – 16:05 Controversy: Is there a Space for MIBG-Imaging and Therapy? Eric Baudin
16:05 – 16:25 In Favour Val Lewington
16:25 – 16:45 Against Irene Virgolini
16:45 – 17:00 Discussion all
17:00 – 18:00 Consensus on Imaging and Therapy of Pheocromocytoma and Paraganglioma Woulter de Herder

 

Friday, January 31, 2020

PRRT of NET

Chairpersons: tba

Time Presentation Title Speaker
09:00 – 09:25 Current State of PRRT Lisa Bodei
09:30 – 09:55 Is Dosimetry Needed for Each Patient? Marta Cremonesi
10:00 – 10:25 Ongoing Studies TBA
11:00 – 11:05 Controversy: Kinase Inhibitor or PRRT, Which First? Jonathan Strosberg
11:05 – 11:25 PRRT First Levent Kabasakal
11:25 – 11:45 Kinase Inhibitor First James C. Yao
11:45 – 12:00 Discussion all
12:00 – 13:00 Consensus on PRRT of NET Jonathan Strosberg

Friday, January 31, 2020

Treatment Monitoring

Chairpersons: tba

Time Presentation Title Speaker
14:00 – 14:25 Definition of Progression in NET Patient: Clinical, Biochemical, Imaging Gregory Kaltsas
14:30 – 14:55 Contribution of Radiology for Treatment Monitoring Clarisse Dromain
15:00 – 15:25 Contribution of Nuclear Medicine for Treatment Monitoring Damian Wild
16:00 – 16:05 Controversy: Are RECIST Criteria Appropriate for Monitoring Response of PRRT? Massimo Falconi
16:05 – 16:25 In Favour Anders Sundin
16:25 – 16:45 Against Kjell Öberg
16:45 – 17:00 Discussion all
17:00 – 18:00 Consensus on Treatment Monitoring Massimo Falconi

Saturday, February 1, 2020

Look into the Future

Chairpersons: tba

Time Presentation Title Speaker
09:00 – 09:25 New Radiotracers for Imaging and Therapy Melpomeni Fani
09:30 – 09:55 Current Trial with New Tracer (Excendin, CXCR4, Antagonist) Damian Wild
10:00 – 10:20 NET Test Lisa Bodei
11:00 – 11:20 PRRT in New Version (Intraarterial Administration, Alpha Emitters) Marta Cremonesi
11:20 – 11:40 Combination Treatment PRRT + Chemotherapy Dermot O’Toole
11:40 – 12:00 Combination Treatment PRRT + Immunotherapy Jaume Capdevila
12:00 – 12:20 Life with NET Catherine Bouvier
12:20 – 12:45 Discussion all
12:45-13:00 Future Directions & Closing Remarks Jolanta Kunikowska Ken Herrmann